Chicago Partners Investment Group 13F: Adds $2.3M to XRAY Stake

On October 27, 2026, Chicago Partners Investment Group boosted its stake in DENTSPLY SIRONA Inc. (XRAY) by 245,199 shares, bringing its total to 266,884 shares. This change was reported in a filing with the SEC, reflecting a value of approximately $2.52 million for the position.

XRAY DENTSPLY SIRONA Inc.

$9.35 ▼ -17.04% year to date

1M 3M YTD

Daily close · Oct 27, 2026

What Changed in Chicago Partners Investment Group's DENTSPLY SIRONA Position

Chicago Partners added 245,199 shares, increasing its position by 1,130.7% from the previous count of 21,685 shares. The reported value of this stake is about $2.52 million, which represents 0.17% of the fund's total reported value of approximately $1.51 billion. The fund's position in DENTSPLY SIRONA ranks 38th out of 1,660 holdings.

Where DENTSPLY SIRONA Fits in Chicago Partners' Portfolio

The increase in shares significantly boosts Chicago Partners' position in DENTSPLY SIRONA. With a portfolio weight of 0.17%, this stake is a notable part of the fund's overall investments, although it remains relatively small compared to its total assets.

Other Institutional Activity in DENTSPLY SIRONA

Several other funds have reported their positions in DENTSPLY SIRONA. AQR Capital Management, LLC increased its stake by 6,493,511 shares, holding a total of 10,458,771 shares valued at about $97.8 million. Lazard Asset Management LLC also grew its holdings by 1,554,042 shares, totaling 8,269,867 shares worth around $77.3 million. Meanwhile, Fuller & Thaler Asset Management Inc. reduced its stake by 94,660 shares, now holding 12,697,269 shares valued at approximately $118.7 million.

DENTSPLY SIRONA Inc. Stock Up 1.4%

As of October 27, 2026, DENTSPLY SIRONA shares are trading at $9.35, which is about equal to the closing price on that date. The stock is currently below its 50-day moving average of $9.79 and its 200-day average of $11.37. It also trades about 36.7% lower than its 52-week high of $14.76, while remaining 12.4% above its 52-week low of $8.32.

Recent Earnings

DENTSPLY SIRONA reported trailing twelve-month revenue of approximately $3.64 billion, but it faced challenges, with a year-over-year revenue growth of -4.1%. The company is set to announce its next earnings report on November 5, 2026.

Insider Buying and Selling at DENTSPLY SIRONA Inc.

Insiders have been active in DENTSPLY SIRONA recently. Jonathan Jay Mazelsky purchased 10,000 shares at an average price of $10.14 on June 12, 2026, reflecting confidence in the company. Brian Mckeon also bought 10,000 shares around the same time, while Clyde Hosein acquired 6,500 shares at $9.99 on June 15, 2026.

Analysts Set New Price Targets

Analysts have maintained various ratings for DENTSPLY SIRONA. On October 26, 2026, Barrington Research maintained an outperform rating with a target price of $13.0, down from $15.0. Other firms like BMO Capital and Piper Sandler have also kept their ratings at market perform and neutral, respectively, with targets ranging from $10.0 to $12.0.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc. develops and markets dental equipment and healthcare products worldwide, operating in segments like Connected Technology Solutions and Essential Dental Solutions. This recent boost in Chicago Partners' holdings indicates a growing interest in the company's long-term prospects.

Bottom Line

Investors will be watching for DENTSPLY SIRONA's upcoming earnings report on November 5, 2026, for further insights into its financial performance. Chicago Partners' significant increase in shares suggests a strategic move in response to market conditions. Further filings and insider activity may provide more context on the company's direction.